Full text is available at the source.
Abstract
Obesity is a major modifiable risk factor in total hip arthroplasty (THA), associated with increased complications.
- Weight loss can reduce the risk of complications in patients undergoing THA.
- Bariatric surgery has been the traditional approach to achieve significant weight loss.
- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are emerging as an alternative for weight management.
- The effectiveness and safety of GLP-1 RAs in this context may warrant further investigation.
Simplified